期刊文献+

中国健康人群与精神分裂症患者细胞色素P450 2C19/P450 2D6遗传多态性的比较 被引量:9

CYP2C19/CYP2D6 Genetic Polymorphisms in Chinese Healthy and Schizophrenia Populations
下载PDF
导出
摘要 目的探讨中国健康人群与精神分裂症患者细胞色素P450 2C19(CYP2C19)/P450 2D6(CYP2D6)遗传多态性的相关性。方法应用PCR与DNA测序相结合的方法,对88名符合ICO-10诊断标准的精神分裂症患者和283名健康志愿者进行了CYP2C19基因多态性分析。同时用此方法对87名精神分裂症患者与93名健康志愿者进行了CYP2D6的基因多态性分析。根据CYP2C19*2(G681A)将精神分裂症患者和健康志愿者基因型分为3组(G/G,G/A,A/A);同样方法将CYP2C19*3(G636A)和CYP2D6(C100T)基因型各分为3组。结果在CYP2C19的检测中,健康志愿者中共检测到6个基因型,在精神分裂症患者中检测到7个基因型。2组间等位基因型差异没有统计学意义(CYP2C19*2χ2=4.954,P>0.05;CYP2C19*3χ2=2.334,P>0.05)。但发现精神分裂症患者突变型纯合子A/A的基因型频率明显高于健康志愿者。在CYP2D6(C100T)的基因型和等位基因型检测中,精神分裂症患者和健康志愿者组间的基因型和等位基因差异无统计学意义(χ2=0.202,P>0.05;χ2=0.066,P>0.05)。结论中国精神分裂症患者与健康人群在细胞色素氧化酶CYP2C19/CYP2D6遗传多态性上差异无统计学意义,CYP2C19*2的突变型纯合子可能是中国精神分裂症患者的一个易感因素。 Objective To investigate whether cytochrome P450 2C19 (CYP2C19) /P450 2D6 (CYP2D6) genetic polymorphisms were associated with schizophrenia in Chinese subjects. Methods 88 schizophrenics meeting criteria ICO-10 were enrolled in the study group and 283 healthy volunteers were involved in the control group. Polymerase chain reaction (PCR) and DNA sequencing were used to examine the CYP2C19(CYP2C19 * 2/CYP2C19 * 3 ). Use the same methods to detect CYP2D6(C100T) genetic polymorphisms of 87 schizophrenics meeting criteria ICO-10 and 93 healthy volunteers. The patients and healthy volunteers were divided into three groups acceding to the CYP2C19 * 2(G681A) genotypes(G/G, G/A, A/A), the same as CYP2C19 * 3 (G636A) and CYP2D6(C100T). Results Six different allelic variants of CYP2C19 gene were observed in the control group and seven different allelic variants of CYP2C19 gene were detected in the schizophrenia group. There is no statistically significant difference in the allele frequencies of CYP2C19 * 2 (X2 = 4.954, P 〉 0.05 ) and CYP2C19 * 3 (X2 = 2. 334, P 〉 0.05 ) between schizophrenia and healthy volunteers. We found the frequency of the homozygote of CYP2C19 * 2 in schizophrenia was conspicuously higher than that of healthy volunteers, There is no significant difference between two groups in CYP2D6(C100T) genotypes and alleles. Condusion Although there is no evidence to show the correlation between CYP2C19/CYP2D6(C100T) genetic polymorphisms and etiology of schizophrenia, the homozygote of CYP2C19 * 2 is possible a genetic susceptibility factor in Chinese subjects with schizophrenia.
出处 《首都医科大学学报》 CAS 2007年第2期176-179,共4页 Journal of Capital Medical University
关键词 精神分裂症 细胞色素P450 2C19 细胞色素P450 2D6 遗传多态性 schizophrenia CYP2C19 CYP2D6 genetic polymorphism
  • 相关文献

参考文献8

  • 1Wedlund P J,Aslanian W S,McAllister C B,et al.Frequency of mephenytoin hydroxylation deficiency in a Caucasian population:Independence from debrisoquine hydroxylation deficiency[J].Clin Pharmacol Ther,1984,36:773-780.
  • 2Wrighton S A,Stevens J C,Becker G W,et al.Isolation and characterization of human liver cytochrome P450 2C19:correlation between 2C19 and S-mephenytoin 4'-hydroxylation[J].Arch of Biochem and Biophys,1993,306:240-245.
  • 3陶恩祥,刘焯霖,陈彪,潘锡榜.中国人细胞色素P450_2D_6基因多态性[J].中华医学遗传学杂志,1998,15(1):34-37. 被引量:13
  • 4Miyuki K,Ichiro I,Kohsuke M,et al.Genetic Polymorphism of Cytochrome P450s,CYP2C19,and CYP2C9 in a Japanese Population[J].Ther Drug Monit,1998,20:243-247.
  • 5ROH H K,Dahl M L,Tybring G,et al.CYP2C19 genotype and phenotype determined by omeprazole in a Korean population[J].Pharmacogenetics,1996,6:547-551.
  • 6Chang M,Dahl M L,Tybring G,et al.Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians:Comparision with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype[J].Pharmacogenetics,1996,5:358-363.
  • 7Persson I,Aklillu E,Rodrigues F,et al.S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians[J].Pharmacogenetics,1996,6:521-526.
  • 8Furman K D,Grimm D R,Mueller T.Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine[J].Pharmacokinetics,2004,14:279-284.

二级参考文献1

  • 1陶恩祥,国外医学.遗传学分册,1996年,19卷,4期,180页

共引文献12

同被引文献60

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部